Mater Research CEO Professor Maher Gandhi has been appointed to a new National Blood Cancer Taskforce to deliver Australia’s first National Strategic Action Plan for Blood Cancer.
Mater researcher Dr Vicki Clifton and Mater Centre for Neuroscience’s Dr Lisa Gillinder have been recognised for their achievements at the 22nd annual Women in Technology (WiT) Awards.
Mater Research CEO and MRI-UQ Director Professor Maher Gandhi and his team report that immune-infiltration is a promising tool to improve outcomes for patients with follicular lymphoma.
A vaccine for childhood respiratory viral infections is a step closer after an Mater Research Institute—UQ immunopathology specialist was awarded a prestigious Children’s Hospital Foundation grant.
More Australians living with follicular lymphoma could benefit from tailored treatment through development of a new clinical scoring model thanks to Mater Research.
Mater’s Fertility Services program is helping couples restore their reproductive health, and the results from research are looking positive.
Mater Research held its annual 3-minute thesis (3MT) competition last week showcasing the work of Higher Degree Research students and honours students at Mater Research.
Mater Research CEO Professor Maher Gandhi has secured additional funding from the Leukaemia Foundation to investigate a new therapeutic approach for follicular lymphoma (FL).
Professor Helen Liley’s addressed the prestigious Boston Children’s Hospital at their 150th Anniversary this month.
Today at Mater there are approximately 200 clinical trials currently underway across many disciplines including nursing and midwifery, all allied health disciplines and medical specialties.
Professor Maher Gandhi will be appointed as Chief Executive Officer of Mater Research and Director of MRI-UQ, effective May 1 2019.
Mater Research and Mater Mothers' Hospitals representatives participated in the Perinatal Society of Australia and New Zealand Annual Congress, aiming to improve maternal and newborn health outcomes.